JP2021094035A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021094035A5 JP2021094035A5 JP2021049567A JP2021049567A JP2021094035A5 JP 2021094035 A5 JP2021094035 A5 JP 2021094035A5 JP 2021049567 A JP2021049567 A JP 2021049567A JP 2021049567 A JP2021049567 A JP 2021049567A JP 2021094035 A5 JP2021094035 A5 JP 2021094035A5
- Authority
- JP
- Japan
- Prior art keywords
- human
- polypeptide
- humanized
- pdcd1
- pdcd1 gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 101100519207 Mus musculus Pdcd1 gene Proteins 0.000 claims 33
- 229920001184 polypeptide Polymers 0.000 claims 30
- 108090000765 processed proteins & peptides Proteins 0.000 claims 30
- 102000004196 processed proteins & peptides Human genes 0.000 claims 30
- 102100040678 Programmed cell death protein 1 Human genes 0.000 claims 20
- 101710089372 Programmed cell death protein 1 Proteins 0.000 claims 20
- 241000283984 Rodentia Species 0.000 claims 14
- 108700024394 Exon Proteins 0.000 claims 12
- 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 claims 11
- 102000048362 human PDCD1 Human genes 0.000 claims 11
- 238000000034 method Methods 0.000 claims 11
- 239000003814 drug Substances 0.000 claims 8
- 229940079593 drug Drugs 0.000 claims 8
- 241000699666 Mus <mouse, genus> Species 0.000 claims 7
- 150000001413 amino acids Chemical class 0.000 claims 5
- 230000003834 intracellular effect Effects 0.000 claims 3
- 238000012544 monitoring process Methods 0.000 claims 3
- 108020004707 nucleic acids Proteins 0.000 claims 3
- 102000039446 nucleic acids Human genes 0.000 claims 3
- 150000007523 nucleic acids Chemical class 0.000 claims 3
- 108020004414 DNA Proteins 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 241000700159 Rattus Species 0.000 claims 2
- 239000012634 fragment Substances 0.000 claims 2
- 241000699670 Mus sp. Species 0.000 claims 1
- 229940124060 PD-1 antagonist Drugs 0.000 claims 1
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 1
- 230000000259 anti-tumor effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 238000011144 upstream manufacturing Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023069178A JP7720349B2 (ja) | 2014-06-19 | 2023-04-20 | ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462014181P | 2014-06-19 | 2014-06-19 | |
| US62/014,181 | 2014-06-19 | ||
| US201462086518P | 2014-12-02 | 2014-12-02 | |
| US62/086,518 | 2014-12-02 | ||
| US201562138221P | 2015-03-25 | 2015-03-25 | |
| US62/138,221 | 2015-03-25 | ||
| JP2016573923A JP6904707B2 (ja) | 2014-06-19 | 2015-06-19 | ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016573923A Division JP6904707B2 (ja) | 2014-06-19 | 2015-06-19 | ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023069178A Division JP7720349B2 (ja) | 2014-06-19 | 2023-04-20 | ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021094035A JP2021094035A (ja) | 2021-06-24 |
| JP2021094035A5 true JP2021094035A5 (enExample) | 2021-09-24 |
| JP7612475B2 JP7612475B2 (ja) | 2025-01-14 |
Family
ID=53546709
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016573923A Active JP6904707B2 (ja) | 2014-06-19 | 2015-06-19 | ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物 |
| JP2021049567A Active JP7612475B2 (ja) | 2014-06-19 | 2021-03-24 | ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物 |
| JP2023069178A Active JP7720349B2 (ja) | 2014-06-19 | 2023-04-20 | ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016573923A Active JP6904707B2 (ja) | 2014-06-19 | 2015-06-19 | ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023069178A Active JP7720349B2 (ja) | 2014-06-19 | 2023-04-20 | ヒト化プログラム細胞死１遺伝子を持つ非ヒト動物 |
Country Status (24)
| Country | Link |
|---|---|
| US (4) | US10390522B2 (enExample) |
| EP (2) | EP3157956B1 (enExample) |
| JP (3) | JP6904707B2 (enExample) |
| KR (2) | KR102482295B1 (enExample) |
| CN (2) | CN110923256B (enExample) |
| AU (2) | AU2015276978B2 (enExample) |
| BR (1) | BR112016029650A2 (enExample) |
| CA (1) | CA2951278A1 (enExample) |
| CY (1) | CY1122940T1 (enExample) |
| DK (1) | DK3157956T3 (enExample) |
| ES (1) | ES2783424T3 (enExample) |
| HR (1) | HRP20200613T1 (enExample) |
| HU (1) | HUE048677T2 (enExample) |
| IL (2) | IL287519B2 (enExample) |
| LT (1) | LT3157956T (enExample) |
| MX (1) | MX2016016903A (enExample) |
| PL (1) | PL3157956T3 (enExample) |
| PT (1) | PT3157956T (enExample) |
| RS (1) | RS60097B1 (enExample) |
| RU (1) | RU2735958C2 (enExample) |
| SG (2) | SG10201811116UA (enExample) |
| SI (1) | SI3157956T1 (enExample) |
| SM (1) | SMT202000184T1 (enExample) |
| WO (1) | WO2015196051A1 (enExample) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8307177B2 (en) | 2008-09-05 | 2012-11-06 | Commvault Systems, Inc. | Systems and methods for management of virtualization data |
| WO2010077634A1 (en) | 2008-12-09 | 2010-07-08 | Genentech, Inc. | Anti-pd-l1 antibodies and their use to enhance t-cell function |
| US9461881B2 (en) | 2011-09-30 | 2016-10-04 | Commvault Systems, Inc. | Migration of existing computing systems to cloud computing sites or virtual machines |
| US20140181038A1 (en) | 2012-12-21 | 2014-06-26 | Commvault Systems, Inc. | Systems and methods to categorize unprotected virtual machines |
| US9378035B2 (en) | 2012-12-28 | 2016-06-28 | Commvault Systems, Inc. | Systems and methods for repurposing virtual machines |
| HRP20210122T1 (hr) | 2013-05-02 | 2021-04-16 | Anaptysbio, Inc. | Protutijela usmjerena protiv programirane smrti-1 (pd-1) |
| DK3157956T3 (da) | 2014-06-19 | 2020-04-27 | Regeneron Pharma | Ikke-humane dyr med et humaniseret gen med programmeret celledød 1 |
| BR112017010793A2 (pt) | 2014-11-24 | 2017-12-26 | Regeneron Pharma | animal não humano geneticamente modificado, camundongo, métodos para produzir um animal não humano geneticamente modificado e de triagem de candidatos a fármaco direcionados a um antígeno de interesse, e, modelo de camundongo. |
| ES2969389T3 (es) | 2014-12-05 | 2024-05-17 | Regeneron Pharma | Animales no humanos que tienen un gen del grupo de diferenciación 47 humanizado |
| EP4399969A3 (en) * | 2014-12-09 | 2024-10-30 | Regeneron Pharmaceuticals, Inc. | Non-human animals having a humanized cluster of differentiation 274 gene |
| US10084873B2 (en) | 2015-06-19 | 2018-09-25 | Commvault Systems, Inc. | Assignment of data agent proxies for executing virtual-machine secondary copy operations including streaming backup jobs |
| US9563514B2 (en) | 2015-06-19 | 2017-02-07 | Commvault Systems, Inc. | Assignment of proxies for virtual-machine secondary copy operations including streaming backup jobs |
| EP3322732A2 (en) | 2015-07-13 | 2018-05-23 | Cytomx Therapeutics Inc. | Anti-pd-1 antibodies, activatable anti-pd-1 antibodies, and methods of use thereof |
| PT3376857T (pt) | 2015-11-20 | 2021-05-27 | Regeneron Pharma | Animais não humanos com um gene humanizado 3 de ativação de linfócitos |
| US10582702B2 (en) * | 2016-02-04 | 2020-03-10 | Regeneron Pharmaceuticals, Inc. | Non-human animals having an engineered ANGPTL8 gene |
| CA3014645C (en) | 2016-02-29 | 2022-10-25 | Regeneron Pharmaceuticals, Inc. | Rodents having a humanized tmprss gene |
| TW202408578A (zh) | 2016-05-13 | 2024-03-01 | 美商再生元醫藥公司 | 藉由投予pd-1抑制劑治療皮膚癌之方法 |
| US11352413B2 (en) | 2016-05-17 | 2022-06-07 | Albert Einstein College Of Medicine | Engineered PD-1 variants |
| IL263160B2 (en) * | 2016-06-03 | 2024-01-01 | Regeneron Pharma | Non-human animals expressing exogenous terminal deoxynucleotidyltransferase |
| US10912287B2 (en) | 2016-06-28 | 2021-02-09 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd | Genetically modified mice expressing humanized PD-1 |
| CN107815466B (zh) | 2016-08-31 | 2020-03-13 | 百奥赛图江苏基因生物技术有限公司 | 人源化基因改造动物模型的制备方法及应用 |
| US11317611B2 (en) | 2016-08-31 | 2022-05-03 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. | Genetically modified non-human animal with human or chimeric PD-L1 |
| EP3666794A1 (en) | 2016-11-01 | 2020-06-17 | AnaptysBio, Inc. | Antibodies directed against programmed death- 1 (pd-1) |
| CN107828722B (zh) * | 2016-11-04 | 2021-07-23 | 北京泰盛生物科技有限公司 | 特异性表达pd-1的干细胞、其鉴定和分离方法及用途 |
| EP3548515A1 (en) * | 2016-12-01 | 2019-10-09 | Regeneron Pharmaceuticals, Inc. | Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging |
| CN110382545A (zh) | 2017-01-09 | 2019-10-25 | 泰萨罗公司 | 用抗pd-1抗体治疗癌症的方法 |
| US11292842B2 (en) | 2017-02-21 | 2022-04-05 | Regeneron Pharmaceuticals, Inc. | Anti-PD-1 antibodies for treatment of lung cancer |
| US10949308B2 (en) | 2017-03-15 | 2021-03-16 | Commvault Systems, Inc. | Application aware backup of virtual machines |
| US10853195B2 (en) | 2017-03-31 | 2020-12-01 | Commvault Systems, Inc. | Granular restoration of virtual machine application data |
| CN109136261B (zh) | 2017-06-19 | 2021-03-16 | 百奥赛图(北京)医药科技股份有限公司 | 人源化cd28基因改造动物模型的制备方法及应用 |
| CN109136274B (zh) * | 2017-06-19 | 2021-04-23 | 百奥赛图江苏基因生物技术有限公司 | 人源化cd40基因改造动物模型的制备方法及应用 |
| CN109136275B (zh) | 2017-06-19 | 2021-03-16 | 百奥赛图(北京)医药科技股份有限公司 | 人源化gitr基因改造动物模型的制备方法及应用 |
| CN109280674B (zh) * | 2017-07-21 | 2020-12-01 | 北京百奥赛图基因生物技术有限公司 | 一种筛选抗体的非人模式动物的构建方法及其应用 |
| EP3585162B1 (en) * | 2017-09-29 | 2023-08-30 | Regeneron Pharmaceuticals, Inc. | Rodents comprising a humanized ttr locus and methods of use |
| CN109666701B (zh) * | 2017-10-13 | 2021-08-24 | 百奥赛图(北京)医药科技股份有限公司 | 一种pd-1基因修饰人源化动物模型的构建方法及其应用 |
| WO2019072241A1 (en) | 2017-10-13 | 2019-04-18 | Beijing Biocytogen Co., Ltd | NON-HUMAN ANIMAL GENETICALLY MODIFIED WITH PD-1 HUMAN OR CHIMERIC |
| JP7361031B2 (ja) | 2017-11-30 | 2023-10-13 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ヒト化ｔｒｋｂ遺伝子座を含む非ヒト動物 |
| KR20250121150A (ko) | 2018-03-26 | 2025-08-11 | 리제너론 파마슈티칼스 인코포레이티드 | 치료제를 시험하기 위한 인간화된 설치류 |
| HUE067361T2 (hu) | 2018-07-16 | 2024-10-28 | Regeneron Pharma | Ditra betegség rágcsáló modelljei és alkalmazásaik |
| CN109266656B (zh) * | 2018-10-10 | 2021-02-19 | 江苏集萃药康生物科技股份有限公司 | 一种PD1人源化BALB/c小鼠模型的构建方法及其应用 |
| CN109452229B (zh) * | 2018-11-19 | 2021-10-22 | 百奥赛图(北京)医药科技股份有限公司 | 狗源化pd-1基因改造动物模型的制备方法及应用 |
| CN112300265B (zh) * | 2019-07-29 | 2022-09-27 | 百奥赛图(北京)医药科技股份有限公司 | Il33基因人源化的非人动物的构建方法和应用 |
| JP2023511626A (ja) * | 2020-01-28 | 2023-03-20 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ヒト化ｐｎｐｌａ３遺伝子座を含む非ヒト動物および使用方法 |
| US11656951B2 (en) | 2020-10-28 | 2023-05-23 | Commvault Systems, Inc. | Data loss vulnerability detection |
| CA3255411A1 (en) | 2022-03-16 | 2025-03-04 | Daiichi Sankyo Co Ltd | COMBINATION OF MULTISPECIFIC MOLECULES AND AN IMMUNE CHECKPOINT INHIBITOR |
| WO2024002259A1 (zh) * | 2022-06-29 | 2024-01-04 | 百奥赛图(北京)医药科技股份有限公司 | 一种osm、osmr、il31ra和/或il31基因修饰的非人动物 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2143491C (en) | 1994-03-01 | 2011-02-22 | Yasumasa Ishida | A novel peptide related to human programmed cell death and dna encoding it |
| US5670356A (en) | 1994-12-12 | 1997-09-23 | Promega Corporation | Modified luciferase |
| US5874304A (en) | 1996-01-18 | 1999-02-23 | University Of Florida Research Foundation, Inc. | Humanized green fluorescent protein genes and methods |
| JP2004501624A (ja) | 2000-06-28 | 2004-01-22 | ジェネティックス・インスチチュート・リミテッド・ライアビリティ・カンパニー | Ｐｄ−ｌ２分子：新規ｐｄ−１リガンドおよびその使用 |
| US6586251B2 (en) | 2000-10-31 | 2003-07-01 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| KR20030066657A (ko) | 2000-11-15 | 2003-08-09 | 오노 야꾸힝 고교 가부시키가이샤 | Ｐｄ-1 결손 마우스 및 그 용도 |
| US20040033497A1 (en) * | 2002-08-13 | 2004-02-19 | Alarcon-Riquelme Marta E. | Polymorphisms of PD-1 |
| CN101899114A (zh) | 2002-12-23 | 2010-12-01 | 惠氏公司 | 抗pd-1抗体及其用途 |
| ES2364335T3 (es) | 2003-12-24 | 2011-08-31 | G2 Inflammation Pty Ltd | Mamífero no humano transgénico que comprende un polinucleótido que codifica el c5ar humano o humanizado. |
| AU2004304665B2 (en) | 2003-12-24 | 2009-03-12 | Novo Nordisk A/S | Transgenic non-human mammal comprising a polynucleotide encoding human or humanized C5aR |
| EP1802193B1 (en) | 2004-10-19 | 2014-04-30 | Regeneron Pharmaceuticals, Inc. | Method for generating a mouse homozygous for a genetic modification |
| CN109485727A (zh) * | 2005-05-09 | 2019-03-19 | 小野药品工业株式会社 | 程序性死亡-1(pd-1)的人单克隆抗体及使用抗pd-1抗体来治疗癌症的方法 |
| US20070054360A1 (en) | 2005-05-12 | 2007-03-08 | Zeren Gao | Compositions and methods for modulating immune responses |
| EP3130350A1 (en) * | 2005-06-08 | 2017-02-15 | Dana-Farber Cancer Institute, Inc. | Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (pd-1)pathway |
| WO2010077634A1 (en) | 2008-12-09 | 2010-07-08 | Genentech, Inc. | Anti-pd-l1 antibodies and their use to enhance t-cell function |
| RU2425880C2 (ru) | 2009-07-30 | 2011-08-10 | Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН | Способ получения трансгенных мышей |
| US8518392B2 (en) | 2009-08-14 | 2013-08-27 | Regeneron Pharmaceuticals, Inc. | Promoter-regulated differentiation-dependent self-deleting cassette |
| TW201134488A (en) * | 2010-03-11 | 2011-10-16 | Ucb Pharma Sa | PD-1 antibodies |
| US8871996B2 (en) * | 2010-06-09 | 2014-10-28 | Regeneron Pharmaceuticals, Inc. | Mice expressing human voltage-gated sodium channels |
| CN104011071B (zh) * | 2011-10-28 | 2017-11-07 | 瑞泽恩制药公司 | T细胞受体基因修饰小鼠 |
| KR102295746B1 (ko) | 2011-10-28 | 2021-09-01 | 리제너론 파아마슈티컬스, 인크. | 유전자 변형된 주요 조직적합성 복합체 마우스 |
| RU2751240C2 (ru) * | 2011-10-28 | 2021-07-12 | Регенерон Фармасьютикалс, Инк. | Гуманизированные il-6 и рецептор il-6 |
| SG10201510056SA (en) | 2011-10-28 | 2016-01-28 | Regeneron Pharma | Genetically modified mice expressing chimeric major histocompatibility complex (mhc) ii molecules |
| ES2748662T3 (es) | 2012-11-05 | 2020-03-17 | Institute For Res In Biomedicine Irb | Roedores inmunodeficientes modificados genéticamente y métodos de uso de los mismos |
| CA2900832A1 (en) | 2013-02-20 | 2014-08-28 | Regeneron Pharmaceuticals, Inc. | Mice expressing humanized t-cell co-receptors |
| JP6444321B2 (ja) | 2013-02-22 | 2018-12-26 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | ヒト化主要組織適合性遺伝子複合体を発現するマウス |
| SMT202500280T1 (it) | 2013-09-23 | 2025-09-12 | Regeneron Pharma | Animali non umani aventi un gene umanizzato della proteina regolatrice del segnale |
| EP3071024B1 (en) | 2013-11-19 | 2018-09-05 | Regeneron Pharmaceuticals, Inc. | Non-human animals having a humanized b-cell activating factor gene |
| SMT202000332T1 (it) | 2014-04-08 | 2020-07-08 | Regeneron Pharma | Animali non umani aventi recettori fc-gamma umanizzati |
| NO2785538T3 (enExample) | 2014-05-07 | 2018-08-04 | ||
| KR102821645B1 (ko) | 2014-05-19 | 2025-06-19 | 리제너론 파마슈티칼스 인코포레이티드 | 인간 epo를 발현하는 유전자 변형된 비-인간 동물 |
| DK3157956T3 (da) * | 2014-06-19 | 2020-04-27 | Regeneron Pharma | Ikke-humane dyr med et humaniseret gen med programmeret celledød 1 |
-
2015
- 2015-06-19 DK DK15738177.3T patent/DK3157956T3/da active
- 2015-06-19 LT LTEP15738177.3T patent/LT3157956T/lt unknown
- 2015-06-19 AU AU2015276978A patent/AU2015276978B2/en active Active
- 2015-06-19 MX MX2016016903A patent/MX2016016903A/es unknown
- 2015-06-19 KR KR1020167035520A patent/KR102482295B1/ko active Active
- 2015-06-19 PT PT157381773T patent/PT3157956T/pt unknown
- 2015-06-19 SI SI201531158T patent/SI3157956T1/sl unknown
- 2015-06-19 HU HUE15738177A patent/HUE048677T2/hu unknown
- 2015-06-19 US US14/744,592 patent/US10390522B2/en active Active
- 2015-06-19 KR KR1020227045421A patent/KR102594863B1/ko active Active
- 2015-06-19 EP EP15738177.3A patent/EP3157956B1/en active Active
- 2015-06-19 SM SM20200184T patent/SMT202000184T1/it unknown
- 2015-06-19 WO PCT/US2015/036649 patent/WO2015196051A1/en not_active Ceased
- 2015-06-19 CA CA2951278A patent/CA2951278A1/en active Pending
- 2015-06-19 SG SG10201811116UA patent/SG10201811116UA/en unknown
- 2015-06-19 HR HRP20200613TT patent/HRP20200613T1/hr unknown
- 2015-06-19 RS RS20200389A patent/RS60097B1/sr unknown
- 2015-06-19 SG SG11201609638RA patent/SG11201609638RA/en unknown
- 2015-06-19 EP EP19215361.7A patent/EP3683238A1/en active Pending
- 2015-06-19 IL IL287519A patent/IL287519B2/en unknown
- 2015-06-19 ES ES15738177T patent/ES2783424T3/es active Active
- 2015-06-19 RU RU2016149434A patent/RU2735958C2/ru active
- 2015-06-19 BR BR112016029650A patent/BR112016029650A2/pt not_active IP Right Cessation
- 2015-06-19 CN CN201911291579.0A patent/CN110923256B/zh active Active
- 2015-06-19 JP JP2016573923A patent/JP6904707B2/ja active Active
- 2015-06-19 CN CN201580033075.2A patent/CN106604635B/zh active Active
- 2015-06-19 PL PL15738177T patent/PL3157956T3/pl unknown
-
2016
- 2016-11-23 IL IL249145A patent/IL249145B/en unknown
-
2018
- 2018-03-20 US US15/926,586 patent/US20180206462A1/en not_active Abandoned
-
2019
- 2019-11-04 US US16/673,119 patent/US11684050B2/en active Active
-
2020
- 2020-04-22 CY CY20201100369T patent/CY1122940T1/el unknown
-
2021
- 2021-03-24 JP JP2021049567A patent/JP7612475B2/ja active Active
- 2021-05-14 AU AU2021203100A patent/AU2021203100B2/en active Active
-
2023
- 2023-04-20 JP JP2023069178A patent/JP7720349B2/ja active Active
- 2023-05-12 US US18/316,461 patent/US20240298619A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021094035A5 (enExample) | ||
| JP2018500896A5 (enExample) | ||
| JP7088992B2 (ja) | ヒト化ｓｉｒｐａ－ｉｌ１５ノックインマウス及びその使用方法 | |
| JP2017521060A5 (enExample) | ||
| KR102594863B1 (ko) | 인간화 프로그램화 세포 사멸 1 유전자를 가지는 비인간 동물 | |
| Hopper et al. | Analysis of the structure and expression pattern of MRP7 (ABCC10), a new member of the MRP subfamily | |
| JP6598798B2 (ja) | ヒト化ｃ５およびｃ３動物 | |
| JP2018533963A5 (enExample) | ||
| Omura et al. | Trpc2-expressing sensory neurons in the main olfactory epithelium of the mouse | |
| US11071290B2 (en) | Genetically modified non-human animal with human or chimeric CTLA-4 | |
| Sommer et al. | Frontline Science: Antagonism between regular and atypical Cxcr3 receptors regulates macrophage migration during infection and injury in zebrafish | |
| EP3289869B1 (en) | Transgenic non-human animal expressing human-specific molecules and human fc gamma receptor family | |
| HRP20231707T1 (hr) | Životinje koje nisu ljudi, koje sadrže humanizirani gen iz diferencijacijske skupine 47 | |
| JP2017514501A5 (enExample) | ||
| US20210171631A1 (en) | Novel Immune Checkpoint Inhibitors | |
| Liang et al. | Desmosomal COP9 regulates proteome degradation in arrhythmogenic right ventricular dysplasia/cardiomyopathy | |
| JP2011501652A5 (enExample) | ||
| US20180243450A1 (en) | Humanized model of kidney and liver disorders | |
| JP2019505216A5 (enExample) | ||
| Afrache et al. | Evolutionary and polymorphism analyses reveal the central role of BTN3A2 in the concerted evolution of the BTN3 gene family | |
| ZA200904184B (en) | Novel gene disruptions, compositions and methods relating thereto | |
| Adams et al. | Myocardial expression, signaling, and function of GPR22: a protective role for an orphan G protein-coupled receptor | |
| CN107041947B (zh) | Fstl1在肝脏等组织抗纤维化的稳态调节中的保护作用与应用 | |
| Okamura et al. | Pharmacogenomics of MDR and MRP subfamilies | |
| ES2961713T3 (es) | Roedores que expresan el complejo C1Q humanizado |